(433) Rapid reduction in pain intensity with oliceridine (TRV130), a novel μ receptor G protein Pathway Selective modulator (μ-GPS), vs. Morphine: an analysis of two phase 2 randomized clinical trials

Eugene R. Viscusi(Thomas Jefferson University), Franck Skobieranda(Ionis Pharmaceuticals (United States)), Lynn R. Webster(Adherent Technologies (United States)), Ruth Ann Subach, Harold S. Minkowitz(Memorial Hermann Memorial City Medical Center), David G. Soergel(Novartis (Switzerland)), David Burt(Social Science Research Solutions (United States))
Journal of Pain
March 24, 2016
10.1016/j.jpain.2016.01.410
Cited by 2

Related Papers

Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council
|Journal of Pain|2016|3.2k
Predicting Aberrant Behaviors in Opioid-Treated Patients: Preliminary Validation of the Opioid Risk Tool
|Pain Medicine|2005|1.1k
Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Acute Pain Management From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists
|Regional Anesthesia & Pain Medicine|2018|583
Risk Factors for Opioid-Use Disorder and Overdose
|Anesthesia & Analgesia|2017|504
Efficacy and Safety of Single and Repeated Administration of 1 Gram Intravenous Acetaminophen Injection (Paracetamol) for Pain Management after Major Orthopedic Surgery
|Anesthesiology|2005|419